关注焦点:Zoom通讯、是德科技及周一值得留意的三只股票——Benzinga报道
Zoom Communications, Keysight Technologies And 3 Stocks To Watch Heading Into Monday - Benzinga
生物技术与制药领域的最新动态
Zoom Communications, Keysight Technologies And 3 Stocks To Watch Heading Into Monday - Benzinga
Novo’s semaglutide fails in phase III Alzheimer’s trials
ICYMI: Week in review, Nov. 17-21, 2025
Biggest gainers and losers for Nov. 17-21, 2025
Med-tech gainers and losers for Nov. 17-21, 2025
Ensign Peak Advisors Inc Sells 5,345 Shares of Agilent Technologies, Inc. $A - MarketBeat
Franklin Resources Inc. Sells 57,129 Shares of Agilent Technologies, Inc. $A - MarketBeat
Free access to BioWorld coronavirus articles
Biogen strikes deal with Versant-backed biotech to expand immune portfolio
Thermo Fisher Scientific (TMO): Assessing Valuation After FDA Wins Expand Cancer and Diagnostic Offerings - simplywall.st
Nobel laureate Carolyn Bertozzi to rejoin Lilly board
RFK skirts promise as CDC alters vaccine-autism webpage
Illumina (ILMN): A Fresh Look at Valuation as Protein Prep Gains Ground in Global Research Labs - simplywall.st
Working together on a net-zero future in healthcare - Roche
Eli Lilly becomes first drugmaker to hit $1 trillion in market value
What’s next in the eye disease pipeline?
Is Agilent’s (A) Steady Dividend a Vote of Confidence or Reflecting Conservative Capital Allocation? - simplywall.st
APOE4 and CRISPR are reframing Alzheimer’s Risk
Generation of biophysical neuron model parameters from recorded electrophysiological responses
RBMX2 links Mycobacterium bovis infection to epithelial–mesenchymal transition and lung cancer progression